Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of microRNAs in type 2 diseases and allergen-specific immunotherapy. | Front Allergy | 2022 | 36172292 | PubTator, text mining | PubMed |
| DNA sensor-associated type I interferon signaling is increased in ulcerative colitis and induces JAK-dependent inflammatory cell death in colonic organoids. | Am J Physiol Gastrointest Liver Physiol | 2022 | 36165492 | PubTator, text mining | PubMed |
| Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer. | BMC Cancer | 2022 | 36162993 | PubTator, text mining | PubMed |
| Viral Clearance with Neutrophil Recovery in a Patient with Active COVID-19 Infection and Refractory Acute Myeloid Leukemia Who Underwent Successful Reinduction with Cytarabine/Idarubicin. | Case Rep Oncol | 2022 | 36157697 | PubTator, text mining | PubMed |
| Cross-GWAS coherence test at the gene and pathway level. | PLoS Comput Biol | 2022 | 36156592 | PubTator, text mining | PubMed |
| Relative Quantification of Proteins in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue Using Multiplexed Mass Spectrometry Assays. | Mol Cell Proteomics | 2022 | 36152753 | PubTator, text mining | PubMed |
| Transcriptome sequencing analysis of echovirus 30 infection reveals its potential pathogenesis. | Front Microbiol | 2022 | 36147849 | PubTator, text mining | PubMed |
| Understanding Host-Virus Interactions: Assessment of Innate Immune Responses in Mastomys natalensis Cells after Arenavirus Infection. | Viruses | 2022 | 36146793 | PubTator, text mining | PubMed |
| Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy. | Pharmaceutics | 2022 | 36145721 | PubTator, text mining | PubMed |
| Correlation between Type I Interferon Associated Factors and COVID-19 Severity. | Int J Mol Sci | 2022 | 36142877 | PubTator, text mining | PubMed |
| microRNAs Control Antiviral Immune Response, Cell Death and Chemotaxis Pathways in Human Neuronal Precursor Cells (NPCs) during Zika Virus Infection. | Int J Mol Sci | 2022 | 36142200 | PubTator, text mining | PubMed |
| Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress. | Nat Immunol | 2022 | 36138183 | PubTator, text mining | PubMed |
| Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors. | Cell Death Dis | 2022 | 36127323 | PubTator, text mining | PubMed |
| SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells. | mBio | 2022 | 36125275 | PubTator, text mining | PubMed |
| Anti-influenza virus activity of the REV-ERBα agonist SR9009 and related analogues. | Antiviral Res | 2022 | 36122620 | PubTator, text mining | PubMed |
| MAGI1 inhibits interferon signaling to promote influenza A infection. | Front Cardiovasc Med | 2022 | 36082118 | PubTator, text mining | PubMed |
| SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells. | Microbiol Spectr | 2022 | 36073824 | PubTator, text mining | PubMed |
| Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic data. | Front Immunol | 2022 | 36072597 | PubTator, text mining | PubMed |
| Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2. | Signal Transduct Target Ther | 2022 | 36071039 | PubTator, text mining | PubMed |
| Elucidation of TRIM25 ubiquitination targets involved in diverse cellular and antiviral processes. | PLoS Pathog | 2022 | 36067236 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=24